86 results on '"condyloma acuminatum"'
Search Results
2. Highlighting a Potential Pitfall: Positive Treponema pallidum Immunohistochemical Stain in a Patient Without Syphilis
- Author
-
Milton Barry Randall, Kristopher R. Fisher, Stacy L. McMurray, Allison Jones, and Cory Pettit
- Subjects
Pathology ,medicine.medical_specialty ,Treponema ,biology ,business.industry ,Dermatology ,General Medicine ,Condyloma Acuminatum ,urologic and male genital diseases ,bacterial infections and mycoses ,biology.organism_classification ,medicine.disease ,Stain ,female genital diseases and pregnancy complications ,Pathology and Forensic Medicine ,Staining ,030207 dermatology & venereal diseases ,03 medical and health sciences ,Syphilis Serodiagnosis ,0302 clinical medicine ,Medicine ,Immunohistochemistry ,Syphilis ,Borrelia burgdorferi ,business - Abstract
The Treponema pallidum antibody immunohistochemical (IHC) stain has improved our ability to detect the organism histologically. We present a case of a man with genital condyloma acuminatum with a positive T. pallidum IHC stain but negative T. pallidum serologies and no syphilitic symptoms. It has been shown that the T. pallidum antibody IHC can cross-react, staining other spirochetes, including Borrelia burgdorferi and the Brachyspira family of intestinal spirochetes. Because of the proximity of our patient's lesions to the anus, and the persistently negative T. pallidum serologies, we believe nontreponemal spirochetes colonized the condyloma, giving a false-positive T. pallidum IHC. This cross-reactivity is a potential diagnostic pitfall and is important for the dermatopathologist to recognize, thereby avoiding false diagnosis of syphilis.
- Published
- 2019
3. Macrophages participate in the immunosuppression of condyloma acuminatum through the PD-1/PD-L1 signaling pathway
- Author
-
Li-Chao Liao, Bai Hu, and Si-Ping Zhang
- Subjects
biology ,medicine.diagnostic_test ,business.industry ,medicine.medical_treatment ,Immunosuppression ,General Medicine ,030204 cardiovascular system & hematology ,Condyloma Acuminatum ,Molecular biology ,Immune tolerance ,Flow cytometry ,Blot ,03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,PD-L1 ,medicine ,biology.protein ,Immunohistochemistry ,business ,Transforming growth factor - Abstract
Background The aim of this study was to investigate whether macrophages can participate in the immunosuppression of condyloma acuminatum (CA) by expressing PD-1/PD-L1. Methods The infiltration of macrophages and expression of programmed death-1 (PD-1) and PD-1 ligand 1 (PD-L1) on wart lesions and in normal skin tissues were detected by immunohistochemistry assay. The amounts of M1- and M2-type macrophages derived from THP-1 cells were measured by flow cytometry. The expression of cytokines on macrophages was examined by using enzyme-linked immunosorbent assay (ELISA). The protein expression of PD-1 and PD-L1 on macrophages was detected by western blotting. Results The macrophages were significantly increased, while PD-1 and PD-L1 were highly expressed on wart lesions compared to normal controls. More M2-like macrophages than M1-type macrophages were present on wart lesions. The M2-like macrophages in the CA groups showed high expression of interleukin-10 (IL-10), transforming growth factor (TGF-β), PD-1, and PD-L1 compared to normal controls. Conclusion Macrophages participate in the immunosuppression of CA by expressing PD-1/PD-L1.
- Published
- 2019
4. Cronkhite—Canada syndrome associated with perianal condyloma acuminatum with malignant transformation
- Author
-
Cheng-Xia Liu, Haiyan Liu, Hai-Feng Lian, Xian-Yong Cheng, Feng Xue, and Wei Wang
- Subjects
Enteroscopy ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Colonoscopy ,General Medicine ,Condyloma Acuminatum ,medicine.disease ,Dermatology ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Capsule endoscopy ,law ,030220 oncology & carcinogenesis ,medicine ,Carcinoma ,Hamartoma ,Cronkhite–Canada syndrome ,030212 general & internal medicine ,Gastrointestinal Polyp ,business - Abstract
Rationale Cronkhite-Canada syndrome (CCS) is a rare non-familial polyposis syndrome characterized by multiple gastrointestinal polyps with the ectodermal triad. To date, many complications of CCS have been reported in the literature, but perianal condyloma acuminatum with malignant transformation has not been included. Patient concerns This report presents the case of a 52-year-old Chinese man who presented with diarrhea, loss of appetite, and weight loss. He developed skin pigmentation and atrophy of the fingernails and toenails. Upper gastrointestinal endoscopy, colonoscopy, capsule endoscopy, and enteroscopy revealed diffuse polyps along the entire digestive tract. Histopathological examination revealed polyps of different pathological types dominated by hamartoma. Physical examination revealed a crissum cauliflower-like neoplasm (2.5 × 2.0 cm). After perianal tumor resection, pathology suggested that this was a perianal condylomatous lesion with malignant transformation, as well as well-differentiated squamous cell carcinoma. Diagnoses These clinical features and endoscopic findings were consistent with CCS which associated with perianal condyloma acuminatum with malignant transformation. Intervention Clinical remission was achieved with glucocorticoid, azathioprine, and nutritional support. Outcome At the 4-year follow-up, the patient had no diarrhea or loss of appetite, had gained 13 kg in weight, and the perianal tumor had not recurred. Lessons No previous report has described CCS in a patient with perianal condyloma acuminatum with malignant transformation. As both conditions are related to immune disorders, their occurrence may be correlated.
- Published
- 2021
5. Reply to 'Immune response of condyloma acuminatum after 5-aminolevulinicacid-photodynamic therapy treatment'
- Author
-
Bai Hu, Li-Chao Liao, and Si-Ping Zhang
- Subjects
business.industry ,Macrophages ,medicine.medical_treatment ,Programmed Cell Death 1 Receptor ,Photodynamic therapy ,General Medicine ,Condyloma Acuminatum ,B7-H1 Antigen ,Immune system ,Photochemotherapy ,medicine ,Cancer research ,Signal transduction ,business ,Signal Transduction - Published
- 2019
6. Condyloma acuminata on the nipple and coronary sulcus of the penis
- Author
-
Ge Song, Wenhui Lun, Yan Wu, and Man Li
- Subjects
medicine.medical_specialty ,Condyloma acuminata ,business.industry ,General Medicine ,Hpv detection ,Condyloma Acuminatum ,medicine.disease ,Dermatology ,Benign tumor ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Coronary sulcus ,Medicine ,Sex organ ,030212 general & internal medicine ,Topical imiquimod ,business ,Penis - Abstract
Rationale Condyloma acuminatum (CA) is a benign tumor primarily caused by infection with human papillomavirus (HPV) type-6 or type-11, lesions of which are most frequently found on the genital and perianal squamous mucosa and skin. CA outside the genitals is not common. Patient concerns A 29-year-old male presented with lesions on the left nipple and coronary sulcus after heterosexual contact. Diagnoses Histopathological examination and HPV detection made a definite diagnosis of CA. Intervention The patient was treated with microwave and topical imiquimod cream. Outcomes After 6 months follow-up, there was no sign of recurrence. Lessons This case shows that we should pay more attention to CA outside the genitals in the process of diagnosis and treatment.
- Published
- 2019
7. The Impact of Anogenital Warts on Health-Related Quality of Life: A 6-Month Prospective Study
- Author
-
Alex Ferenczy, James A. Mansi, François Coutlée, Eduardo L. Franco, Sam Ratnam, William E. Fisher, Mélanie Drolet, Elizabeth Maunsell, and Marc Brisson
- Subjects
Adult ,Male ,Microbiology (medical) ,Sexually transmitted disease ,Canada ,medicine.medical_specialty ,Pediatrics ,Time Factors ,Adolescent ,Health Status ,Sexual Behavior ,Dermatology ,Young Adult ,Papillomavirus Vaccines ,Surveys and Questionnaires ,Secondary Prevention ,medicine ,Humans ,Prospective Studies ,Young adult ,Prospective cohort study ,business.industry ,Public health ,Vaccination ,Public Health, Environmental and Occupational Health ,virus diseases ,Condyloma Acuminatum ,Self Concept ,Surgery ,Quality-adjusted life year ,Infectious Diseases ,Condylomata Acuminata ,Quality of Life ,Female ,Public Health ,Quality-Adjusted Life Years ,business ,Follow-Up Studies - Abstract
The burden of anogenital warts will be a determining factor when making decisions about the type of human papillomavirus (HPV) vaccine to be used (bivalent or quadrivalent) and whether to vaccinate males. We conducted a multicenter prospective study to (1) describe the impact of anogenital warts on quality of life and (2) estimate the quality-adjusted life-years (QALYs) lost due to anogenital warts.Between September 2006 and February 2008, 272 patients with a first or recurrent episode of anogenital warts were recruited from the clinical practices of 42 physicians across Canada. Quality of life was measured at recruitment, and 2 and 6 months later with the EuroQol, Short Form-12, short Spielberg State-Trait Anxiety Inventory, and HPV impact profile. The duration of an episode and QALYs lost due to anogenital warts were estimated among 51 incident cases recruited within 90 days of disease onset.Anogenital warts had a significant impact on the quality of life. This negative impact was similar for first and recurrent episodes, and lasted as long as lesions persisted. Anogenital warts had the greatest negative impact on usual activities, pain/discomfort, and anxiety/depression, and on self-image, sexual activity, and partner issues and possible transmission. The median duration of a first anogenital wart episode amongst incident cases was 125 days and resulted in QALYs lost of 0.017 to 0.041, which is equivalent to 6 to 15 days of healthy life lost.The burden of anogenital warts is substantial and should be considered by physicians and public health officials when making recommendations about HPV vaccination..
- Published
- 2011
8. Prevalence and Risk Factors of Chlamydia trachomatis Cervicitis in Pregnant Women at the Genital Tract Infection in Obstetrics Unit Care at Botucatu Medical School, São Paulo State University - UNESP, Brazil
- Author
-
Eliane Passarelli Vieira, Andrea da Rocha Tristão, Marilza Vieira Cunha Rudge, Larissa Doddi Marcolino, Mariângela Esther Alencar Marques, Márcia Guimarães da Silva, Helio R. Nunes, Jossimara Polettini, and Bruna Ribeiro de Andrade Ramos
- Subjects
Adult ,medicine.medical_specialty ,Adolescent ,Population ,Cervicitis ,Chlamydia trachomatis ,medicine.disease_cause ,Young Adult ,Pregnancy ,Risk Factors ,Prevalence ,medicine ,Humans ,education ,Cervix ,Gynecology ,education.field_of_study ,Chlamydia ,business.industry ,Obstetrics ,Vaginal flora ,Obstetrics and Gynecology ,General Medicine ,Odds ratio ,Chlamydia Infections ,Condyloma Acuminatum ,medicine.disease ,Uterine Cervicitis ,Pregnancy Complications ,medicine.anatomical_structure ,Female ,business ,Brazil - Abstract
OBJECTIVE: To evaluate the prevalence of and risk factors for Chlamydia trachomatis cervicitis in pregnant women seen at the Genital Tract Infection in Obstetrics Unit Care in Botucatu Medical School Sao Paulo State University - UNESP. MATERIALS AND METHODS: Between June 2006 and February 2008 101 pregnant women were included in this study. During the gynecologic examination cervical secretions were collected using cytobrush Plus GT (CooperSurgical Inc) to assess C. trachomatis using polymerase chain reaction. Vaginal flora were examined by Gram stain and sociodemographic data were extracted from medical records. RESULTS: Of the 101 patients 26 (25.7%) were positive for C. trachomatis. The median age of the infected group was 24 years (range = 13-40 y) and 48.5% of them had abnormal vaginal flora. The presence of chlamydial infection was associated with smoking (odds ratio [OR] = 2.67 95% confidence interval [CI] = 1.01-7.19) residing in a city with fewer than 100000 inhabitants (OR = 2.86 95% CI = 1.03-7.94) presence of condyloma acuminatum (p = .03) and presence of discreet inflammation on Pap smear (p = .02). CONCLUSIONS: The prevalence of C. trachomatis is high in pregnant women seen at the Genital Infection Unit Care UNESP and is related to many risk factors. Therefore its screening is extremely important in reducing obstetrical and neonatal complications.
- Published
- 2011
9. Strong Inverse Correlation Between MicroRNA-125b and Human Papillomavirus DNA in Productive Infection
- Author
-
Alcina F. Nicol, Xin Wu, Carlo M. Croce, Jinmai Jiang, Gianpiero Di Leva, Fengting Yan, Stefano Volinia, Gerard J. Nuovo, Thomas D. Schmittgen, Nena Chin, and Gregory A. Otterson
- Subjects
Cervix Uteri ,Cervical intraepithelial neoplasia ,Article ,Pathology and Forensic Medicine ,Mice ,medicine ,Animals ,Humans ,Papillomaviridae ,Molecular Biology ,Cells, Cultured ,biology ,Papillomavirus Infections ,HPV infection ,virus diseases ,Epithelial Cells ,Cell Biology ,Epidermodysplasia verruciformis ,Condyloma Acuminatum ,Uterine Cervical Dysplasia ,medicine.disease ,biology.organism_classification ,Virology ,female genital diseases and pregnancy complications ,Koilocyte ,Reverse transcriptase ,MicroRNAs ,Real-time polymerase chain reaction ,Condylomata Acuminata ,DNA, Viral ,Epidermodysplasia Verruciformis ,Female ,Warts - Abstract
Infection by the human papillomavirus (HPV) is a cause of cervical intraepithelial neoplasia (CIN) and cancer. microRNA (miRNA) in situ analysis of the transformation zone epithelia, the site of initial cervical HPV infection, showed that miRNAs let-7c, — 99a, 26a, and 125b were the most abundantly expressed. In situ testing of CIN 1 showed a dramatic reduction in miR-125b expression in the koilocytes, the cytologic marker of productive HPV infection. A marked reduction in miR-125b was likewise observed in the HPV-infected cells of the condyloma acuminatum, verruca vulgaris, and epidermodysplasia verruciformis. Reverse transcriptase in situ polymerase chain reaction (PCR) showed that the pre-miRNA 125b was present in the koilocyte, suggesting direct inactivation of the mature miRNA. HEK cells transfected with only the antimiR-125b showed perinuclear halos equivalent to HPV-infected koilocytes. NIH 3T3 cells transfected with the HPV 16 full-length genome and mimetic miR-125b showed a marked reduction in viral DNA and protein synthesis by quantitative PCR and in situ-based analyses, respectively (P=0.002). Alternatively, cotransfection with anti-miR-125b and HPV 16 markedly increased HPV DNA (P=0.002). Sequence analyses showed strong homology between L2 of different HPV genotypes and miR-125b. Transfection with HPV 16 L2 resulted in a marked reduction in miR-125b levels in the NIH 3T3 cells. HPV L2-induced inactivation of miR-125b is associated with the classic cytologic changes of the koilocyte, and the exogenous application of mimetic miR-125b markedly inhibits HPV DNA synthesis.
- Published
- 2010
10. Human Papilloma Virus Type and Recurrence Rate After Surgical Clearance of Anal Condylomata Acuminata
- Author
-
Nicolas Demartines, Aris D’Ambrogio, Roland Sahli, Jean-Claude Givel, Michael Cotton, Stéphane Yerly, and Hanifa Bouzourene
- Subjects
Adult ,Male ,Microbiology (medical) ,Sexually transmitted disease ,medicine.medical_specialty ,Genotype ,Anal Canal ,Dermatology ,Hospitals, University ,Surgical Clearance ,Recurrence ,Surveys and Questionnaires ,medicine ,Humans ,Papillomaviridae ,skin and connective tissue diseases ,biology ,Human papillomavirus 11 ,business.industry ,Papillomavirus Infections ,Public Health, Environmental and Occupational Health ,virus diseases ,Anal canal ,Condyloma Acuminatum ,Human papillomavirus 6 ,biology.organism_classification ,Anus ,medicine.disease ,eye diseases ,Surgery ,stomatognathic diseases ,Infectious Diseases ,medicine.anatomical_structure ,Condylomata Acuminata ,Papilloma ,Female ,Viral disease ,business ,Monte Carlo Method ,Switzerland - Abstract
Anal condylomata acuminata (ACA) are caused by human papilloma virus (HPV) infection which is transmitted by close physical and sexual contact. The result of surgical treatment of ACA has an overall success rate of 71% to 93%, with a recurrence rate between 4% and 29%. The aim of this study was to assess a possible association between HPV type and ACA recurrence after surgical treatment.We performed a retrospective analysis of 140 consecutive patients who underwent surgery for ACA from January 1990 to December 2005 at our tertiary University Hospital. We confirmed ACA by histopathological analysis and determined the HPV typing using the polymerase chain reaction. Patients gave consent for HPV testing and completed a questionnaire. We looked at the association of ACA, HPV typing, and HIV disease. We used chi, the Monte Carlo simulation, and Wilcoxon tests for statistical analysis.Among the 140 patients (123 M/17 F), HPV 6 and 11 were the most frequently encountered viruses (51% and 28%, respectively). Recurrence occurred in 35 (25%) patients. HPV 11 was present in 19 (41%) of these recurrences, which is statistically significant, when compared with other HPVs. There was no significant difference between recurrence rates in the 33 (24%) HIV-positive and the HIV-negative patients.HPV 11 is associated with higher recurrence rate of ACA. This makes routine clinical HPV typing questionable. Follow-up is required to identify recurrence and to treat it early, especially if HPV 11 has been identified.
- Published
- 2009
11. Patterns of Treatment of External Genital Warts in Australian Sexual Health Clinics
- Author
-
Rob Carter, Andrea Morrow, Suzanne M. Garland, John Chuah, Anna McNulty, Russell Waddell, Christopher K Fairley, Jenny McCloskey, E. Lynne Conway, Alicia N. Stein, and Marie Pirotta
- Subjects
Adult ,Male ,Microbiology (medical) ,Sexually transmitted disease ,medicine.medical_specialty ,Pediatrics ,Adolescent ,Population ,Dermatology ,Genital warts ,Young Adult ,Surveys and Questionnaires ,Epidemiology ,Humans ,Medicine ,Young adult ,education ,Retrospective Studies ,Reproductive health ,education.field_of_study ,business.industry ,Australia ,Public Health, Environmental and Occupational Health ,Retrospective cohort study ,Middle Aged ,Condyloma Acuminatum ,medicine.disease ,Surgery ,Treatment Outcome ,Infectious Diseases ,Condylomata Acuminata ,Cryotherapy ,Female ,Genital Diseases, Male ,business ,Genital Diseases, Female - Abstract
BACKGROUND: External genital warts are a common sexually transmitted viral disease. We describe the patterns of treatment for initial presentations of external genital warts (EGWs) in Australian sexual health centers. METHODS: This was a retrospective audit of 489 case notes from consecutive individuals who presented with a new diagnosis of EGWs to 1 of 5 major sexual health clinics in Australia. Eligibility criteria were consecutive patients aged 18 to 45 years inclusively, presenting with first ever episode of EGWs from January 1, 2004. Exclusion criteria were patients who were immunocompromised, including HIV infection, or enrollment in a treatment study for EGWs. RESULTS: The median age at presentation of women was 23.2 years and of men 26.8 years. One quarter (n = 127) of patients had another sexually transmitted infection diagnosed at presentation. Nearly half of the patients (n = 224) presented only once for treatment. Most often, patients were treated with a monotherapy (n = 382/489; 78%), usually cryotherapy (257; 53%). Staff applied treatment in 361 (74%) cases. There was wide variation across sites, possibly reflecting local policies and budgets. We found no difference in wart resolution (n = 292; 60%) by initial treatment chosen. CONCLUSIONS: The diagnosis and treatment of genital warts constitute a sizable proportion of clinical visits to the audited sexual health services and require a large input of staff time to manage, including the application of topical treatments. Our results help complete the picture of the burden of EGWs on Australian sexual health centers before the introduction of the HPV vaccine.
- Published
- 2009
12. Sinecatechins, a Defined Green Tea Extract, in the Treatment of External Anogenital Warts
- Author
-
Silvio Tatti, Claus Thielert, James M. Swinehart, Axel Mescheder, Karl R. Beutner, and Hoda Tawfik
- Subjects
Adult ,Male ,Sexually transmitted disease ,medicine.medical_specialty ,Adolescent ,Green tea extract ,Catechin ,law.invention ,Ointments ,Sinecatechins ,Double-Blind Method ,Randomized controlled trial ,Recurrence ,law ,medicine ,Humans ,Sex organ ,Clinical efficacy ,Aged ,Anus Diseases ,Tea ,Plant Extracts ,business.industry ,Obstetrics and Gynecology ,Middle Aged ,Condyloma Acuminatum ,Dermatology ,Surgery ,Clinical trial ,Treatment Outcome ,Condylomata Acuminata ,Female ,Genital Diseases, Male ,business ,Genital Diseases, Female - Abstract
To estimate the clinical efficacy of topical sinecatechins, a defined green tea extract, in the treatment of external genital and perianal warts.This was a randomized, double-blind, vehicle-controlled trial involving 502 male and female patients aged 18 years and older, with 2-30 anogenital warts ranging from 12 to 600 mm(2) total wart area. Patients applied sinecatechins ointment 15% or 10% or vehicle (placebo) three times daily for a maximum of 16 weeks or until complete clearance of all warts, followed by a 12-week treatment-free follow-up to assess recurrence.Complete clearance of all baseline and newly occurring warts was obtained in 57.2% and 56.3% of patients treated with sinecatechins ointment 15% and 10%, respectively, compared with 33.7% for vehicle (both P.001). Significance was observed at weeks 4 and 6 and all subsequent visits. Numbers needed to treat were 4.3 and 4.4. Partial clearance rates of at least 50% were reported for 78.4% and 74.0% of patients in the sinecatechins ointment 15% and 10% groups compared with 51.5% of vehicle patients. During follow-up, recurrence of any wart was observed in 6.5%, 8.3%, and 8.8% in the sinecatechins ointment 15% group, sinecatechins ointment 10% group, and vehicle patients, respectively. A total of 3.7%, 8.3%, and 0.0% developed new warts, respectively. A total of 87.7% and 87.3% of patients in the sinecatechins ointment 15% and 10% groups, and 72.1% of vehicle patients experienced application site reactions; 49.2%, 46.2%, and 65.4% of those, respectively, were mild or moderate.Topical sinecatechins ointments 15% and 10% are effective and well-tolerated in the treatment of anogenital warts.ClinicalTrials.gov, www.clinicaltrials.gov, NCT00449982.I.
- Published
- 2008
13. Genital Warts Among 18- to 59-Year-Olds in the United States, National Health and Nutrition Examination Survey, 1999–2004
- Author
-
Maya R. Sternberg, Lauri E. Markowitz, Thu-Ha Dinh, and Eileen F. Dunne
- Subjects
Adult ,Male ,Microbiology (medical) ,Sexually transmitted disease ,medicine.medical_specialty ,Adolescent ,National Health and Nutrition Examination Survey ,Substance-Related Disorders ,Sexual Behavior ,Dermatology ,Genital warts ,Prevalence ,Humans ,Medicine ,Human papillomavirus ,Demography ,Hpv types ,business.industry ,Public Health, Environmental and Occupational Health ,virus diseases ,Middle Aged ,Condyloma Acuminatum ,Nutrition Surveys ,medicine.disease ,Health Surveys ,United States ,Surgery ,Sexual Partners ,Infectious Diseases ,Sexual behavior ,Condylomata Acuminata ,Multivariate Analysis ,Female ,Viral disease ,business - Abstract
Genital warts are caused by human papillomavirus (HPV); over 90% are due to HPV types 6 and 11. We determined the percentage of persons who reported having been diagnosed with genital warts in the United States from 1999--2004.We collected genital wart diagnosis history and sociodemographic and sexual behavior data from 8849 sexually active men and women aged 18 to 59 years as part of the National Health and Nutrition Examination Survey, 1999--2004.Overall, 5.6% of 18-to 59-year olds reported having ever been diagnosed with genital warts. The percentage was higher in women (7.2%, 95% CI, 6.2%-8.4%) than in men (4%, 95% CI, 3.2%-5.0%). History of genital wart diagnosis peaked among 25- to 34-year-old women (10.4%) and 35- to 44-year-old men (6.0%). Sex, age, race/ethnicity, number of lifetime sex partners, and cocaine/street drug use were associated with genital warts in multivariate analysis.These are the first national data on the burden of genital warts in the United States. The substantial burden of genital warts could be reduced by a prophylactic HPV vaccine to types 6 and 11.
- Published
- 2008
14. A Practical Approach to Warts in the Emergency Department
- Author
-
Bruce E. Herman and Howard M. Corneli
- Subjects
Sexually transmitted disease ,Child abuse ,medicine.medical_specialty ,Adolescent ,Uterine Cervical Neoplasms ,Poison control ,Pediatrics ,Skin Diseases ,Suicide prevention ,Diagnosis, Differential ,Keratolytic Agents ,Intensive care ,medicine ,Humans ,Papillomavirus Vaccines ,Child ,Podophyllin ,business.industry ,Papillomavirus Infections ,virus diseases ,Child Abuse, Sexual ,General Medicine ,Emergency department ,Condyloma Acuminatum ,Dermatology ,humanities ,Surgery ,Sexual abuse ,Condylomata Acuminata ,Cryotherapy ,Pediatrics, Perinatology and Child Health ,Emergency Medicine ,Female ,Medicine, Traditional ,Warts ,Emergency Service, Hospital ,Salicylic Acid ,business - Abstract
Although cutaneous warts are one of the most common skin conditions affecting children, their management can be challenging, especially in complex cases and even more so during a single emergency department encounter. Anogenital warts require particular attention because of their possible but nonspecific association with sexual abuse. This review will focus on cutaneous warts and anogenital warts, with a discussion of their recognition and treatment, especially in the emergency department. The medicolegal implications of anogenital warts in children are also reviewed.
- Published
- 2008
15. Syphilis Among Female Sex Workers in Southwestern China: Potential for HIV Transmission
- Author
-
Xiao-Yun Cao, Ye Yang, Yan-hui Song, Yuhua Ruan, Guangming Qin, Benli Song, Shu Liang, Li Zhang, Zheng-qing Jiang, Xinxu Li, Yiming Shao, Kanglin Chen, Xi Chen, Han-Zhu Qian, Wei Hu, Chun Hao, Ning Wang, Hui Xing, and Jun Wang
- Subjects
Microbiology (medical) ,Sexually transmitted disease ,education.field_of_study ,Cross-sectional study ,business.industry ,Gonorrhea ,Population ,Public Health, Environmental and Occupational Health ,Dermatology ,Condyloma Acuminatum ,medicine.disease ,Infectious Diseases ,Unsafe Sex ,Immunology ,medicine ,Syphilis ,education ,business ,Sex work ,Demography - Abstract
The objective of this study was to investigate the prevalence and risk factors of syphilis infection among female sex workers in a southwestern Chinese city along a drug trafficking route. From December 2004 to January 2005 343 female sex workers (FSWs) were recruited through community outreach and peer referring. Confidential questionnaire interviews were administered to collect information on sexual and other sexually transmitted diseases/HIV risk behaviors. Cervical and blood samples were collected to test for syphilis and HIV antibodies and Neisseria gonorrhoeae infection; Condyloma acuminatum infection was diagnosed clinically. Of 343 FSWs 15.7% were infected with syphilis. The prevalence of HIV gonorrhea and C. acuminatum was 0.6% 2.0% and 1.5% respectively. The subtype of 2 HIV-1 infections was both CRF 07BC. Nearly 10% of FSWs reported using illicit drugs. Consistent use inconsistent use and never use of condoms with commercial sex clients in the last month were reported by 53.9% 38.5% and 7.6% FSWs respectively. Longer duration of sex work (odds ratio [OR] = 1.98; 95% confidence interval [CI] = 1.08 -3.62) working at low-end establishments (OR = 2.03; 95% CI = 1.10 -3.76) and if primary sex partners had sex with other women in the past 6 months (OR = 2.06; 95% CI = 1.08 -3.91) were independently associated with syphilis infection. High prevalence of syphilis and overlapped unprotected commercial sex and drug using behaviors among FSWs along a drug-trafficking route may suggest a potential for rapid spread of HIV from injection drug users to FSWs and then to the general population and underscore the urgency of preventive interventions to break the bridge of FSWs for HIV/sexually transmitted disease spread. (authors)
- Published
- 2006
16. Radical Excision and Mesh-Skin Grafting for Giant Anorectal Condyloma Acuminatum
- Author
-
G Karakatsanis, E. Xenidis, G. Chaidemenos, Chionatti Kastoridou, A. Souparis, Olga Mourellou, and Maria Kogia
- Subjects
Laser surgery ,Chemotherapy ,Giant condyloma acuminatum ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Dermatology ,General Medicine ,Surgical operation ,Condyloma Acuminatum ,medicine.disease ,Surgery ,Radical excision ,Topical agents ,medicine ,Skin grafting ,business - Abstract
BACKGROUND Giant Condyloma Acuminatum (GCA) presents difficulties in therapeutic management, mainly due to local invasion and recurrences. Treatment measures vary from topical agents to aggressive methods such as surgical excision, radiation, laser surgery, chemotherapy, immunotherapy or their combination. METHOD A 48-year-old heterosexual, HIV-negative male with a 20 year-year history of GCA, following an unsuccessful surgical operation, underwent radical excision with immediate mesh-skin grafting. CONCLUSION The absence of relapse and the excellent cosmetic results obtained one and a half years post-operative may put this treatment option in the first line of treatment choices for GCA
- Published
- 2006
17. Simultaneous Human Papillomavirus 6 (HPV 6) -Positive Condyloma Acuminatum, HPV 3l-Positive Bowen's Disease, and Non HPV-Associated Extramammary Paget's Disease Coexisting Within an Area Presenting Clinically as Condyloma Acuminatum
- Author
-
Kiyofumi Egawa and Yumi Honda
- Subjects
Sexually transmitted disease ,Bowen's disease ,Pathology ,medicine.medical_specialty ,business.industry ,Dermatology ,General Medicine ,Condyloma Acuminatum ,medicine.disease ,Extramammary Paget's disease ,Dyskeratosis ,Pathology and Forensic Medicine ,Cytokeratin ,medicine.anatomical_structure ,Scrotum ,medicine ,Viral disease ,business - Abstract
An 83-year-old Japanese man presented with multiple verrucous papules clustering on a plaque located on the frontal aspect of the scrotum. Histologically, there were three distinct epithelial changes compatible with condyloma acuminatum, Bowen's disease, and extramammary Paget's disease (EMPD). By in situ hybridization, the zone of condyloma acuminatum was positive for HPV 6 and well demarcated from HPV 31-positive Bowen's disease. EMPD was negative for targeted HPV 6/11/16/18/31/33 probes. Immunohistochemically, Paget's cells expressing cytokeratin 7 were distributed as scattered single cells or clusters mainly in the lower part of the HPV 6/31-positive epithelium. To the best of our knowledge, this is the first reported case of the occurrence of condyloma acuminatum, Bowen's disease, and EMPD within the same lesion.
- Published
- 2005
18. Rate and Predictors of New Genital Warts Claims and Genital Warts-Related Healthcare Utilization Among Privately Insured Patients in the United States
- Author
-
Jill E. Koshiol, Jeanne M. Pimenta, and Samantha A. Laurent
- Subjects
Adult ,Male ,Microbiology (medical) ,Gerontology ,Sexually transmitted disease ,Healthcare use ,Adolescent ,Population ,Dermatology ,Genital warts ,Insurance Claim Review ,Health claims on food labels ,Risk Factors ,medicine ,Humans ,Prospective Studies ,education ,education.field_of_study ,Insurance, Health ,business.industry ,Incidence ,Incidence (epidemiology) ,Age Factors ,Public Health, Environmental and Occupational Health ,virus diseases ,Health Care Costs ,Middle Aged ,Patient Acceptance of Health Care ,Condyloma Acuminatum ,medicine.disease ,United States ,Health Planning ,Infectious Diseases ,Healthcare utilization ,Condylomata Acuminata ,Female ,business ,Demography - Abstract
Background: Little non-clinic-based data are available on incident genital warts rates and related healthcare use. Goal: The goal of this study was to describe the incidence and predictors of genital warts and associated healthcare utilization patterns among a group of privately insured patients in the United States. Study: Health claims were evaluated prospectively from 5,914,107 privately insured individuals. Results: The rate of new genital warts claims per 100,000 person-years at risk, age-standardized to the 2001 U.S. privately insured population, increased from 117.8 in 1998 to 205.0 in 2001. The highest rates were among 20- to 29-year-olds. The majority of claims came from dermatology and obstetrics/gynecology. Conclusions: The incidence of genital warts, as measured by the rate of new claims, appears to be rising. Age associations with the rate of new genital warts claims differed by gender; these associations may be influenced by changes in health-seeking behavior, potentially driven by health awareness.
- Published
- 2004
19. Postoperative Follow-Up of Anal Condylomata Acuminata in HIV-Positive Patients
- Author
-
Edenilson Eduardo Calore, Carmen Ruth Manzione, and Sidney Roberto Nadal
- Subjects
Adult ,Male ,Sexually transmitted disease ,medicine.medical_specialty ,Adolescent ,Polymerase Chain Reaction ,Recurrence ,Surgical oncology ,medicine ,Humans ,Anal cancer ,Papillomaviridae ,Acquired Immunodeficiency Syndrome ,Intraepithelial neoplasia ,biology ,business.industry ,Gastroenterology ,General Medicine ,Middle Aged ,Condyloma Acuminatum ,Anus Neoplasms ,medicine.disease ,Anus ,biology.organism_classification ,Dermatology ,Colorectal surgery ,Surgery ,Ki-67 Antigen ,medicine.anatomical_structure ,Condylomata Acuminata ,DNA, Viral ,business ,Follow-Up Studies - Abstract
PURPOSE: The purpose of this study was to analyze the postoperative follow-up of HIV-positive patients with anal condylomata acuminata, associating recurrence to the AIDS status. METHODS: Ninety-seven male, homosexual patients with anal condylomata were submitted to surgical treatment from August 1992 to December 1997. Specimens were obtained for histologic investigation of Ki-67 cell proliferation marker and for polymerase chain reaction to define the human papillomavirus type. The patients were advised to return weekly during the first month, and monthly up to the sixth month, to evaluate recurrence. Patients with high-grade anal intraepithelial neoplasia remain in follow-up. RESULTS: Histology revealed low-grade anal intraepithelial neoplasia in 81.44 percent of patients and high-grade lesions in 18.56 percent. The results showed that high-grade lesions were not more frequent in late-stage AIDS patients. Ki-67 expression, a cell proliferation marker, was greater in high-grade than in low-grade anal intraepithelial neoplasia, but had no association with AIDS status. Nononcogenic human papillomavirus 6 and 11 were the commonest types. Comparing papillomavirus types and anal intraepithelial grade, we noticed that both oncogenic and nononcogenic types were responsible for high-grade lesions. All patients healed and 51 (52.6 percent) had recurrence up to the sixth month. AIDS status and papillomavirus type were not associated with recurrence. However, high-grade anal intraepithelial neoplasia patients had more recurrence than those with low-grade lesions. Topical treatment failed in 20 patients (41.6 percent), and these were submitted to new surgical treatment. All of them were in the late stage of AIDS. Three who had high-grade lesions in the first operation had low-grade lesions in specimens from the second surgery. The same histologic pattern was observed in 17 patients who had low-grade lesions in warts removed in the first operation. Other patients with high-grade lesions had no recurrence or evolution to invasive carcinoma from five to ten years of follow-up. CONCLUSION: High-grade anal intraepithelial neoplasia and late-stage AIDS are risk factors for recurrence of anal condylomata.
- Published
- 2003
20. Giant Condyloma Acuminatum
- Author
-
Habib Akbulut, Levent Verim, Levent Gürkan, Nesimi Buyukbabani, Selma Sönmez Ergün, and Yasemin Balsever Kural
- Subjects
Sexually transmitted disease ,Male ,Giant condyloma acuminatum ,Pathology ,medicine.medical_specialty ,Verrucous carcinoma ,business.industry ,Dermatology ,General Medicine ,Condyloma Acuminatum ,Middle Aged ,medicine.disease ,Genital warts ,Lesion ,Condylomata Acuminata ,medicine ,Atypia ,Humans ,Surgery ,Radical surgery ,medicine.symptom ,Genital Diseases, Male ,business - Abstract
BACKGROUND Giant condyloma acuminatum is a warty lesion that is characterized by its large size and propensity to infiltrate into deeper tissues contrasting with its microscopically benign pattern. It is proposed that giant condyloma represents an intermediate lesion between condyloma acuminatum and verrucous carcinoma. OBJECTIVE A primary therapeutic option of giant condyloma is radical surgery with or without adjunctive chemotherapy. Because of the tumor's large extent in this case, curative therapy would have been achieved by wide surgical excision. METHOD We present a morphologically and histologically classic example of giant condyloma with respect to origin from common genital warts. The reason for extensive exophytic growth was due to delay in therapy because of the patient's self neglect but not due to immune deficiency. The patient was treated with wide surgical excision. RESULTS The postoperative period was uneventful, allowing satisfactory functional and cosmetic results. CONCLUSION This case is an interesting case because of its exceptionally huge size without any deep tissue involvement and tissue atypia. This suggests that giant condyloma is an intermediate condition that exhibits a continuous tendency for growth.
- Published
- 2003
21. The Impact of HIV Infection and Immunodeficiency on Human Papillomavirus Type 6 or 11 Infection and on Genital Warts
- Author
-
Linda Ahdieh, Eva Piessens, Howard Minkoff, Robert D. Burk, Laila I. Muderspach, Heather Watts, Joel M. Palefsky, Ruth M. Greenblatt, Stewart L. Massad, Kathryn Anastos, Alvaro Muñoz, Ann Duerr, Robert S. Klein, Michael J. Silverberg, Paula Schuman, Keerti V. Shah, and Susan Cu-Uvin
- Subjects
Adult ,Microbiology (medical) ,Sexually transmitted disease ,Adolescent ,HIV Infections ,Dermatology ,Genital warts ,Cohort Studies ,Acquired immunodeficiency syndrome (AIDS) ,HIV Seropositivity ,Prevalence ,medicine ,Humans ,Sex organ ,Prospective Studies ,Sida ,Papillomaviridae ,Immunodeficiency ,Aged ,AIDS-Related Opportunistic Infections ,biology ,business.industry ,Public Health, Environmental and Occupational Health ,virus diseases ,Middle Aged ,Condyloma Acuminatum ,medicine.disease ,biology.organism_classification ,Virology ,United States ,CD4 Lymphocyte Count ,Infectious Diseases ,Condylomata Acuminata ,Immunology ,Female ,Viral disease ,business ,Genital Diseases, Female - Abstract
HIV infection and associated immunodeficiency are known to alter the course of human papillomavirus (HPV) infections and of associated diseases.This study investigated the association between HIV and HPV and genital warts.HPV testing and physical examinations were performed in two large prospective studies: the Women's Interagency HIV Study (WIHS) and the HIV Epidemiology Research Study (HERS). Statistical methods incorporating dependencies of longitudinal data were used to examine the relationship between HIV and HPV and genital warts.A total of 1008 HIV-seronegative and 2930 HIV-seropositive women were enrolled in the two studies. The prevalence of HPV 6 or 11 was 5.6 times higher in HIV-seropositive women in the WIHS and 3.6 times higher in the HERS. Genital wart prevalence increased by a factor of 3.2 in the WIHS and 2.7 in the HERS in HIV-seropositive women. In the WIHS, infection with HPV type 6 or 11, in comparison with no HPV infection, was associated with odds of genital wart prevalence of 5.1 (95% CI: 2.9-8.8), 8.8 (95% CI: 6.1-12.8), and 12.8 (95% CI: 8.8-18.8) in HIV-seronegative women, HIV-seropositive women withor =201 CD4 cells/microl, and HIV-seropositive women withor =200 CD4 cells/microl, respectively. In the HERS, infection with HPV type 6 or 11 was associated with odds of 2.7 (95% CI: 1.6-4.6), 4.9 (95% CI: 3.2-7.7), and 5.3 (95% CI: 3.3-8.5) in these same groups. Other HPV types showed a similar dose-response relation, but of substantially lower magnitude and statistical significance.HIV infection and immunodeficiency synergistically modified the relation between HPV 6 or 11 infection and genital wart prevalence.
- Published
- 2002
22. Activity of HspE7, a Novel Immunotherapy, in Patients with Anogenital Warts
- Author
-
Stephen E. Goldstone, Neefe John R, Joel M. Palefsky, and Winnett Mark T
- Subjects
Male ,Sexually transmitted disease ,medicine.medical_specialty ,Chaperonins ,Papillomavirus E7 Proteins ,Recombinant Fusion Proteins ,Physical examination ,Bacterial Proteins ,Double-Blind Method ,medicine ,Humans ,Anal cancer ,Papillomaviridae ,Retrospective Studies ,HspE7 ,Anus Diseases ,Intraepithelial neoplasia ,Cross-Over Studies ,medicine.diagnostic_test ,business.industry ,Gastroenterology ,virus diseases ,Chaperonin 60 ,Oncogene Proteins, Viral ,General Medicine ,Condyloma Acuminatum ,Anus Neoplasms ,medicine.disease ,Dermatology ,Surgery ,Squamous intraepithelial lesion ,Epidermoid carcinoma ,Condylomata Acuminata ,Carcinoma, Squamous Cell ,Female ,Immunotherapy ,business ,Carcinoma in Situ - Abstract
PURPOSE: Human papillomavirus causes anogenital squamous intraepithelial lesions, warts, and cancer. Treatment of squamous intraepithelial lesions to prevent cancer often requires extensive surgery. We tested a human papillomavirus-specific immunotherapy, HspE7, as a potential alternative. METHODS: HspE7 was constructed by fusing heat shock protein Hsp65 from bacille Calmette-Guerin to E7 protein from human papillomavirus-16. Improvement in pathologic diagnosis of patients with persistent high-grade squamous intraepithelial lesions was studied in an open-label trial (HspE7 500 μg monthly ×3). Anogenital warts were not a trial parameter, but a retrospective review of the medical records of the first 22 patients enrolled at one site was undertaken to estimate the quality and frequency of responses of anogenital warts. Patients with warts by physical examination at baseline were scored at 24 weeks as to the percent reduction in wart size. RESULTS: Fourteen of the 22 patients had warts at baseline. At Week 24, 3 of the 14 patients had complete resolution of their warts, and 10 had warts reduced in size an estimated 70 to 95 percent. The remaining patient’s warts increased in size. The reduction in size in most patients greatly diminished the procedure necessary for complete ablation. No serious or severe adverse events were related to HspE7. CONCLUSIONS: A retrospective review of patients’ medical records suggests that HspE7 may be broadly active in anogenital warts. This activity crosses multiple human papillomavirus types. The warts improved substantially but usually did not totally disappear within six months. Patient follow-up continues. A new randomized, placebo-controlled trial is underway to evaluate these findings.
- Published
- 2002
23. Efficacy and Safety of Imiquimod Versus Podophyllotoxin in the Treatment of Anogenital Warts
- Author
-
Werner Aberer, Tanja Strimitzer, Peter Komericki, and Merve Akkilic-Materna
- Subjects
Adult ,Male ,Microbiology (medical) ,Sexually transmitted disease ,medicine.medical_specialty ,Adolescent ,Imiquimod ,Dermatology ,law.invention ,Young Adult ,Keratolytic Agents ,Adjuvants, Immunologic ,Randomized controlled trial ,law ,medicine ,Clinical endpoint ,Humans ,Podophyllotoxin ,Intention-to-treat analysis ,business.industry ,Public Health, Environmental and Occupational Health ,Middle Aged ,Condyloma Acuminatum ,Confidence interval ,Intention to Treat Analysis ,Surgery ,Treatment Outcome ,Infectious Diseases ,Condylomata Acuminata ,Aminoquinolines ,Female ,business ,medicine.drug - Abstract
Background: Anogenital warts are a common sexually transmitted disease caused by human papillomaviruses. Despite the fact, that imiquimod and podophyllotoxin represent common topical agents, direct comparative studies lack. This work compares the effectiveness and safety of self-applied imiquimod 5% cream and podophyllotoxin 0.5% solution. Methods: Within 2 years, consecutive patients presenting with untreated anogenital warts were included in a randomized, open label trial. The primary endpoint was complete clearance at the end of treatment (4 weeks after the start with podophyllotoxin, 16 weeks after the start of imiquimod therapy). Side effects were evaluated as a secondary endpoint. Results: A total of 45 patients, 7 women and 35 men, of whom 5 were circumcised, concluded the treatment and were eligible for evaluation. The rates of clearance of baseline warts among treatment groups were 72% (95% confidence interval [CI], 52%-86%) in the podophyllotoxin group and 75% (95% CI, 53%-98%) in the imiquimod group. Statistically, clearance rates were identical (P = 1). The differences in side effects between treatment groups were statistically not significant (P = 0.24). Conclusions: The current study, a direct comparison of both, confirms the previously obtained mathematical data, that imiquimod 5% cream and podophyllotoxin 0.5% solution have an identical beneficial effect on anogenital warts and are associated with identical and acceptable side effects. Both substances constitute effective and safe treatments of untreated anogenital warts in immunocompetent individuals.
- Published
- 2011
24. Condylomata Acuminata (Genital Warts)
- Author
-
Alan B. Fleischer, Steven R. Feldman, Rebecca Glenn, and Charles A. Parrish
- Subjects
Adult ,Male ,Microbiology (medical) ,Sexually transmitted disease ,medicine.medical_specialty ,Adolescent ,Office Visits ,Population ,Dermatology ,urologic and male genital diseases ,Genital warts ,Age Distribution ,Obstetrics and gynaecology ,Epidemiology ,Ambulatory Care ,medicine ,Humans ,Sex organ ,Sex Distribution ,Child ,skin and connective tissue diseases ,education ,Aged ,Gynecology ,education.field_of_study ,Obstetrics ,business.industry ,Public Health, Environmental and Occupational Health ,virus diseases ,Middle Aged ,Patient Acceptance of Health Care ,Condyloma Acuminatum ,medicine.disease ,United States ,female genital diseases and pregnancy complications ,Infectious Diseases ,Condylomata Acuminata ,Medicine ,Female ,Genital Diseases, Male ,business ,Genital Diseases, Female ,Psychosocial ,Specialization - Abstract
Background Condylomata acuminata (genital warts), caused by the human papillomavirus, are common and sexually transmitted. However, the use of healthcare services for condylomata has never been characterized from a national probability sample study. Goal To understand better the demographics of patients seen by physicians for this disorder. Study design Data from office visits for warts, both condylomata and noncondylomatous types, were obtained from the 1994 to 1998 National Ambulatory Medical Care Survey. Results The age distribution of those treated for condylomata peaked in 20- to 39-year-olds, with more than 70% of patients in this age category. A younger and wider age distribution was seen in patients with noncondylomatous warts. Women accounted for 67% of the population seen for condylomata, whereas a more equal number of women and men were seen for noncondylomatous warts. Per capita healthcare use for condylomata was equal between blacks and whites, and whites had almost five times more per capita healthcare use than blacks for noncondylomatous warts. Obstetrician/gynecologists were the most commonly consulted physicians for condylomata. Per capita condylomata visits per physician were highest for obstetrician/gynecologists, dermatologists, and urologists, and lower for all other physicians. Conclusions The difference in age distribution between condylomata and noncondylomatous visits likely results from differing modes of transmission and age at first sexual contact. Females are more likely than males to use health care for condylomata, which may be attributable to increased prevalence, differences in treatment efficacy, differences in the gender frequency of genital health screenings, or psychosocial causes. Healthcare use for condylomata appears equal between blacks and whites. Patients with condylomata acuminata were most often seen by obstetrician/gynecologists, whereas patients with noncondylomatous warts most often consulted dermatologists. The fact that per capita condylomata visits per physician were highest for obstetrician/gynecologists, dermatologists, and urologists may imply that specialists in these fields have expertise in treating these patients.
- Published
- 2001
25. Treatment of External Genital Warts in Men Using 5% Imiquimod Cream Applied Three Times a Week, Once Daily, Twice Daily, or Three Times a Day
- Author
-
Darron R. Brown, John M. Douglas, Mary L. Owens, M.H. Smith, Kenneth H. Fife, and Alex Ferenczy
- Subjects
Adult ,Male ,Microbiology (medical) ,Sexually transmitted disease ,medicine.medical_specialty ,Interferon Inducers ,Erythema ,Imiquimod ,Dermatology ,Antibodies, Viral ,Neopterin ,Drug Administration Schedule ,Genital warts ,law.invention ,Randomized controlled trial ,law ,medicine ,Humans ,Papillomaviridae ,Ulcer ,Aged ,Dose-Response Relationship, Drug ,business.industry ,Incidence (epidemiology) ,Public Health, Environmental and Occupational Health ,Middle Aged ,Condyloma Acuminatum ,medicine.disease ,Surgery ,Regimen ,Infectious Diseases ,Condylomata Acuminata ,Aminoquinolines ,medicine.symptom ,business ,medicine.drug - Abstract
Background Medical therapy for genital warts remains suboptimal. The topical interferon and cytokine inducer, imiquimod, has been proved effective for the treatment of external genital and perianal warts, but there is a substantial difference in the response rates between men and women. When 5% imiquimod cream is applied three times a week up to 16 weeks, approximately two thirds of women treated with imiquimod achieve complete clearance of genital warts, whereas only about one third of men clear completely. Goal This study was undertaken to determine whether more frequent application of topical imiquimod cream would improve the rate of genital wart clearance in men. Study design A randomized treatment trial involving adult men with biopsy-proven genital warts was conducted at nine centers in the United States and Canada using four different application frequencies. Results Complete clearance rates during the 16-week treatment period were as follows for the different imiquimod treatment frequencies: three times a week (35 %), once daily (28 %), twice daily (24%), and three times a day (27%)(P = 0.88). The four treatment groups all showed comparable reductions in the total lesion area, with a median of more than a 90% reduction in the lesion area by the end of treatment. There was a significant increase in the incidence and severity of local skin reactions including erythema, vesicle formation, ulceration, and excoriation as the dosing frequency increased from three times a week to three times a day. Conclusions In this study, the optimal dosage regimen was the approved three times a week regimen. More frequent application (up to three times a day) did not improve clearance and was associated with an increase in local adverse events.
- Published
- 2001
26. Expression of Ki-67 can assist in predicting recurrences of low-grade anal intraepithelial neoplasia in AIDS
- Author
-
Sidney Roberto Nadal, Lis Vilela de Almeida, Carmen Ruth Manzione, M.J. Cavaliere, Edenilson Eduardo Calore, and Luiza Lina Villa
- Subjects
Adult ,Male ,Sexually transmitted disease ,medicine.medical_specialty ,Pathology ,Anal Carcinoma ,medicine.medical_treatment ,Gastroenterology ,Internal medicine ,medicine ,Carcinoma ,Humans ,Risk factor ,Retrospective Studies ,Acquired Immunodeficiency Syndrome ,business.industry ,Immunosuppression ,General Medicine ,Condyloma Acuminatum ,Anus Neoplasms ,Anus ,medicine.disease ,Immunohistochemistry ,Ki-67 Antigen ,medicine.anatomical_structure ,Epidermoid carcinoma ,Condylomata Acuminata ,Neoplasm Recurrence, Local ,business ,Carcinoma in Situ - Abstract
PURPOSE: The incidence of anogenital squamous-cell carcinoma was observed to have increased since the beginning of the human immunodeficiency virus infection epidemic among male homosexuals, both with acquired immunodeficiency syndrome and without acquired immunodeficiency syndrome. It seems that immunosuppression is the most important risk factor for the progression of anogenital lesions, recurrences of anal condyloma, and development of anal carcinoma, in particular in acquired immunodeficiency syndrome. High-grade anal intraepithelial neoplasia was predominantly observed in the human immunodeficiency virus-positive men. We have also observed a high rate of recurrences of anal lesions in cases of high-grade anal intraepithelial neoplasia. However, there are many cases of recurrences of low-grade anal intraepithelial neoplasia that cannot be predicted by routine histologic studies. By using immunohistochemical methods, we studied the expression of Ki-67 in epithelial cells of low-grade anal intraepithelial neoplasia of patients with acquired immunodeficiency syndrome to try to predict recurrence of these lesions. METHODS: Anal biopsies of 38 patients were studied retrospectively. Of these patients, 14 had no recurrences (Group 1), and 24 patients had recurrence of the anal lesions before one year of follow-up (Group 2). RESULTS: The median percentage of Ki-67-positive cells in Group 1 was 6.3±7.03 and in Group 2 was 24.1±16,72. The difference between Groups 1 and 2 was statistically significant (P
- Published
- 2001
27. MIB-1 Immunostaining Is a Beneficial Adjunct Test for Accurate Diagnosis of Vulvar Condyloma Acuminatum
- Author
-
Edyta C. Pirog, Christina Isacson, and Yao-Tseng Chen
- Subjects
Sexually transmitted disease ,Pathology ,medicine.medical_specialty ,Biology ,Polymerase Chain Reaction ,Pathology and Forensic Medicine ,Vulva ,Diagnosis, Differential ,Polyps ,medicine ,Humans ,Overdiagnosis ,Papillomaviridae ,neoplasms ,In Situ Hybridization ,Vulvar Diseases ,Papilloma ,Vulvar Neoplasms ,Papillomavirus Infections ,Nuclear Proteins ,Vulvar Condyloma Acuminatum ,Antigens, Nuclear ,Condyloma Acuminatum ,digestive system diseases ,Tumor Virus Infections ,Ki-67 Antigen ,medicine.anatomical_structure ,Condylomata Acuminata ,DNA, Viral ,Female ,Surgery ,Anatomy ,Differential diagnosis ,Immunostaining - Abstract
The histopathologic diagnosis of vulvar condyloma acuminatum is often based on architectural features that are not specific for human papillomavirus (HPV) infection. Because HPV-associated lesions show increased cellular proliferation, the authors evaluated the usefulness of MIB-1 immunostaining as an aid in the differential diagnosis of cases equivocal for condyloma. The MIB-1 immunostaining pattern was correlated with HPV DNA detection in condyloma acuminatum (CON-A; n = 15), "consistent with condyloma" (c/w CON-A; n = 26), fibroepithelial polyp (FEP; n = 14), and squamous papilloma (n = 10). HPV was detected in 100% of the CON-A cases, and all cases demonstrated MIB-1-positive nuclei in the upper two thirds of the epithelial thickness. With this definition of MIB-1 positivity, there was complete concordance between MIB-1 positivity and HPV detection for all cases (kappa = 0.88). Of the cases c/w CON-A, 17 of 26 (65%) were positive for both MIB-1 and HPV, and could be reclassified as CON-A, whereas 35% were identified as an overdiagnosis based on negative results. In addition, two cases of FEP were MIB-1 and HPV positive, and thus were identified as an underdiagnosis. These results suggest significant overdiagnosis of cases equivocal for condyloma, and indicate that MIB-1 immunostaining is a beneficial adjunctive test when the morphologic features are suggestive but not diagnostic for CON-A.
- Published
- 2000
28. Disseminated Mucosal Papilloma/Condyloma Secondary to Human Papillomavirus
- Author
-
Jane M. Emanuel, Kenneth L. Sims, and John W. Bishop
- Subjects
Sexually transmitted disease ,Pathology ,medicine.medical_specialty ,biology ,business.industry ,virus diseases ,Mucous membrane ,Condyloma Acuminatum ,medicine.disease ,biology.organism_classification ,Koilocyte ,Pathology and Forensic Medicine ,Vulva ,medicine.anatomical_structure ,Dysplasia ,medicine ,Papilloma ,Surgery ,Anatomy ,Papillomaviridae ,business - Abstract
This report details the histopathologic findings in a woman who acquired the human papillomavirus 6/11 in her late teens and developed papilloma/condyloma of the nasopharynx, oropharynx, anogenital region, urethra, and urinary bladder. General evaluations of immune function reveal no defect, and there was no evidence of HIV infection. The morphologic expression of HPV 6/11 infection appears to be completely dependent on the mucosal epithelium affected. The complete spectrum of benign and premalignant epithelial changes induced by the human papillomavirus family-papilloma, verrucae, condyloma acuminatum, epithelial hyperplasia, and dysplasia-were present in this patient with a single papillomavirus infection. We postulate that this patient has a specific immune deficiency that limits her ability to control local infection and spread of the papillomavirus.
- Published
- 1998
29. Risk Factors for Incident and Recurrent Condylomata Acuminata Among Women
- Author
-
Barbara McKnight, Karen J. Sherman, Janet R. Daling, Laurel A. Habel, Andy Stergachis, and Stephen K. Van Den Eeden
- Subjects
Adult ,Washington ,Microbiology (medical) ,Sexually transmitted disease ,medicine.medical_specialty ,Adolescent ,Sexual Behavior ,Dermatology ,Disease ,urologic and male genital diseases ,Recurrence ,Humans ,Medicine ,Risk factor ,skin and connective tissue diseases ,business.industry ,Incidence ,Incidence (epidemiology) ,Public Health, Environmental and Occupational Health ,Case-control study ,virus diseases ,Middle Aged ,Condyloma Acuminatum ,female genital diseases and pregnancy complications ,Surgery ,Population based study ,Infectious Diseases ,Condylomata Acuminata ,Case-Control Studies ,Female ,Viral disease ,business ,Genital Diseases, Female ,Demography - Abstract
Condylomata acuminata is one of the most common sexually transmitted diseases (STDs) diagnosed in the United States, yet relatively little research has been conducted on the determinants of this disease in well-defined populations.To determine the exposures that predispose a woman to the development of condylomata acuminata or genital warts.A population-based case-control study was conducted among enrollees of Group Health Cooperative of Puget Sound. Patients (94 women with incident and 55 women with recurrent condyloma) were diagnosed between April 1, 1987 and September 30, 1991. Control subjects were 133 women without a history of genital warts. An in-person interview was conducted to collect information on subject characteristics, exposures, and on all episodes of genital warts.Women with five or more partners within the 5 years before reference date were over seven times more likely to have incident condyloma (relative risk [RR], 7.5; 95% confidence interval [CI], 3.1-18.1) and over 12 times more likely to have recurrent condyloma (RR, 12.8; 95% CI, 4.2-38.9) compared with women with only one sexual partner during this time period. An increased risk of incident condyloma was also associated with a history of any STD (RR, 2.6; 95% CI, 1.1-5.8), a history of oral herpes (RR, 2.2; 95% CI, 1.1-4.4), and a history of allergies (RR, 2.0 95% CI, 1.0-3.8). Our data did not support a strong association between risk of condyloma and smoking or recent use of oral contraceptives.Our results suggest that risk of condyloma is primarily related to sexual behavior. We did not observe a strong association between risk of condyloma and many of the exposures considered to be potential cofactors for anogenital cancers associated with other types of human papillomaviruses.
- Published
- 1998
30. LACK OF EVIDENCE FOR A ROLE OF HUMAN PAPILLOMAVIRUSES IN TRANSITIONAL CELL CARCINOMA OF THE BLADDER
- Author
-
Gérard Orth, Olivier Aynaud, and Pascal Tranbaloc
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,Urology ,Polymerase Chain Reaction ,law.invention ,law ,Humans ,Medicine ,Papillomaviridae ,Polymerase ,Polymerase chain reaction ,Aged ,Southern blot ,Aged, 80 and over ,Carcinoma, Transitional Cell ,Urinary bladder ,biology ,business.industry ,Papillomavirus Infections ,HPV infection ,virus diseases ,Histology ,Middle Aged ,Condyloma Acuminatum ,medicine.disease ,female genital diseases and pregnancy complications ,Blotting, Southern ,Tumor Virus Infections ,Transitional cell carcinoma ,medicine.anatomical_structure ,Urinary Bladder Neoplasms ,DNA, Viral ,biology.protein ,Female ,business - Abstract
Purpose: In view of the conflicting results reported in the literature, we assessed the involvement of human papillomaviruses (HPV) in the development of transitional cell carcinoma of the bladder.Materials and Methods: A total of 58 bladder papillomatous proliferations was histologically examined and analyzed for the presence of HPV deoxyribonucleic acid (DNA) sequences by Southern blot hybridization and the polymerase chain reaction (PCR) method.Results: Typical features of condyloma acuminatum were observed in the bladder specimen of a patient with urethral condylomatosis. Of the specimens 57 had histological features of transitional cell carcinoma but no known signs of HPV infection. HPV-6 DNA was detected in the condylomatous tumor. However, no HPV DNA was detected in the 57 bladder cancers by Southern blot hybridization and polymerase chain reaction.Conclusions: These findings do not support an etiological role of HPV in the development of transitional cell bladder cancer.
- Published
- 1998
31. Condyloma acuminata in infants and children
- Author
-
Mahdi Budayr, Raymond N. Ankney, and Richard Moore
- Subjects
Male ,Sexually transmitted disease ,Health Knowledge, Attitudes, Practice ,medicine.medical_specialty ,Aftercare ,Rectum ,Age Distribution ,Surveys and Questionnaires ,Internal medicine ,Humans ,Medicine ,Sex organ ,Child ,Gynecology ,Anus Diseases ,Intraepithelial neoplasia ,business.industry ,Incidence ,Incidence (epidemiology) ,Decision Trees ,Infant, Newborn ,Gastroenterology ,Infant ,General Medicine ,Condyloma Acuminatum ,United States ,Colorectal surgery ,medicine.anatomical_structure ,Sexual abuse ,Condylomata Acuminata ,Child, Preschool ,Female ,business ,Colorectal Surgery - Abstract
PURPOSE: Condyloma acuminata are anogenital warts caused by a human papillomavirus. Human papillomavirus is a tissue-specific, site-specific, double-stranded DNA virus, which is capable of inducing high-grade genital intraepithelial neoplasia and malignancy. The incidence of anogenital warts in the pediatric age group is rising, and sexual abuse has been implicated as a potential cause. METHODS: Accumulated data from separate questionnaires sent to practicing colorectal surgeons who are members of The American Society of Colon and Rectal Surgeons and fellows in colon and rectal training programs have been analyzed. RESULTS: Thirty percent of those polled responded to our survey. Of the respondents, 93 percent see less than two pediatric cases per year. Seventy-two percent stated that tissue specimens would be sent routinely for histopathologic identification. Although 73 percent of surgeons consider anogenital warts a potentially sexually transmitted disease, only 26 percent reported screening for other sexually transmitted diseases. A diagnostic and therapeutic protocol is followed by 19 percent of respondents. Patient follow-up varied from six months (43 percent) to lifelong examinations (3 percent). Sixty-four percent of respondents agreed that a diagnostic and therapeutic protocol based on current knowledge would be beneficial. CONCLUSION: We conclude that colon and rectal surgeons have a low exposure to anogenital warts in infants and children. Furthermore, we believe that a diagnostic and therapeutic protocol based on the current literature would be helpful.
- Published
- 1996
32. Therapeutic Efficacy and Complications of Excisional Biopsy of Condyloma acuminatum
- Author
-
Mark H. Stoler, Anna Choi, Peter G. Pappas, Sean J. d'ARCY, Richard C. Reichman, Lawrence Corey, Lisa M. Demeter, William Bonnez, and David Oakes
- Subjects
Adult ,Male ,Microbiology (medical) ,Sexually transmitted disease ,medicine.medical_specialty ,Biopsy ,medicine.medical_treatment ,Cryotherapy ,Dermatology ,Antiviral Agents ,Cryosurgery ,Recurrence ,Risk Factors ,medicine ,Retrospective analysis ,Humans ,Retrospective Studies ,medicine.diagnostic_test ,business.industry ,Public Health, Environmental and Occupational Health ,Condyloma Acuminatum ,Combined Modality Therapy ,Surgery ,Treatment Outcome ,Infectious Diseases ,Condylomata Acuminata ,Treatment modality ,Female ,Interferons ,Viral disease ,business - Abstract
Background and Objectives: Among the various treatment modalities for condyloma acuminatum, excisional cold-blade surgery appears excellent but it has been little studied and little used, particularly for lesions not located in the perianal area. Goals: To examine the efficacy and complications of scissors excision of single anogenital warts. Study Design: Retrospective analysis of single warts completely excised with scissors for the purpose of biopsy before patient entry in a randomized, placebo-controlled study of the efficacy and safety of various parenteral interferons in combination with cryotherapy. Results: Of 152 patients entered in the main study, 85 patients were available for analysis. At 4 and 16 weeks after excision, 16 of 85 (19%) and 14 of 68(21%) of the excised lesions recurred. After at least 6 months of follow-up, 2 of 11 (18%) of the excision sites demonstrated some evidence of pigmentation changes. Conclusions: Scissors excision of single anogenital warts has a high rate of success and acceptable long-term side-effects.
- Published
- 1996
33. Histologic and biomolecular aspects of papillomatosis of the vulvar vestibule in relation to human papillomavirus
- Author
-
Stávale Jn, de Deus Jm, de Lima Gr, and Focchi J
- Subjects
Adult ,Sexually transmitted disease ,Pathology ,medicine.medical_specialty ,Vestibular papillomatosis ,Papillomatosis ,Polymerase Chain Reaction ,Vulva ,Humans ,Medicine ,Papillomaviridae ,Cervix ,Papilloma ,Vulvar Neoplasms ,integumentary system ,urogenital system ,business.industry ,Papillomavirus Infections ,HPV infection ,Nucleic Acid Hybridization ,Obstetrics and Gynecology ,Condyloma Acuminatum ,medicine.disease ,female genital diseases and pregnancy complications ,Koilocyte ,Tumor Virus Infections ,medicine.anatomical_structure ,Condylomata Acuminata ,DNA, Viral ,Female ,Vulvar Diseases ,medicine.symptom ,business - Abstract
Objective To determine whether human papillomavirus (HPV) plays a role in the genesis of papillomatosis of the vulvar vestibule. Methods We conducted a study based on molecular hybridization and histology of biopsy material obtained from the inner surface of the labia minora of 25 women with papillomatosis of the vulvar vestibule who presented no abnormal clinical, cytologic, or colposcopic changes in the cervix or vagina. These women were compared with 24 women with condyloma acuminatum of the vulvar vestibule and with ten women with normal vulvar epithelium and no cervicovaginal changes. All patients included in the study were 35 years or younger, and none was pregnant. Results Papillomatosis of the vulvar vestibule was rarely found to be HPV positive by molecular hybridization (one of 25, 4%, by dot blot hybridization and one of 15, 6.67%, by polymerase chain reaction [PCR]). This result did not differ significantly from that obtained for the group with normal vulvar epithelium (none of 10 by dot blot and none of six by PCR), but did differ (P = .001) from the result obtained for the group with condyloma acuminatum of the vestibule (12 of 24, 50%, by dot blot and six of six, 100%, by PCR). The biomolecular study of vestibular papillomatosis showed that focal koilocytosis was not correlated with HPV infection. Conclusion Papillomatosis of the vulvar vestibule is not associated with HPV and should be considered a paraphysiologic formation of the vulvar epithelium. The diagnosis of vulvar HPV infection should be avoided in the absence of more explicit clinical-histologic evidence, with no need for biopsies or unnecessary treatments.
- Published
- 1995
34. Current therapy for recurrent and extensive anal warts
- Author
-
Susan M. Congilosi and Robert D. Madoff
- Subjects
Sexually transmitted disease ,Anus Diseases ,Chemotherapy ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Gastroenterology ,General Medicine ,Condyloma Acuminatum ,Anus ,Colorectal surgery ,Surgery ,Surgical methods ,Immunocompromised Host ,medicine.anatomical_structure ,Condylomata Acuminata ,Recurrence ,Surgical oncology ,Anal warts ,Interferon Type I ,medicine ,Humans ,business - Abstract
PURPOSE: This study was undertaken to review the literature regarding the current therapy for recurrent and extensive anal warts. METHODS: The available treatments for condyloma acuminatum are reviewed with particular regard to their efficacy for recurrent or extensive anal lesions. Topical agents, surgical methods, and the use of interferon are discussed. Treatment of anal warts in the immunocompromised patient is also addressed. CONCLUSIONS: Although small lesions may be responsive to repeated applications of topical agents, more extensive lesions require surgical or combination treatment. Intralesional interferon may be a useful adjunct to surgical methods to decrease recurrence.
- Published
- 1995
35. HIV, sexually transmitted diseases and gynaecologic disorders in women
- Author
-
J. S. A. Fennema, E. J. C. Van Ameijden, R. A. Coutinho, and A. van den Hoek
- Subjects
Sexually transmitted disease ,medicine.medical_specialty ,Trichomoniasis ,business.industry ,Obstetrics ,Immunology ,virus diseases ,Condyloma Acuminatum ,medicine.disease ,Genital warts ,law.invention ,Infectious Diseases ,Condom ,Acquired immunodeficiency syndrome (AIDS) ,law ,Pelvic inflammatory disease ,medicine ,Immunology and Allergy ,Risk factor ,business - Abstract
Objectives : To determine the incidence of sexually transmitted diseases (STD ; gonorrhoea, early syphilis, Chlamydia trachomatis infection, trichomoniasis and primary genital herpes) and gynaecologic disorders (vaginal candidiasis, anaerobic vaginosis, genital ulcerations of unknown cause, pelvic inflammatory disease, recurrent genital herpes, recurrent genital warts) in a cohort of HIV-infected and non-infected drug-using prostitutes in Amsterdam between 1986 and 1992. Design : A subgroup of 212 female drug users with a history of prostitution, who made at least one visit to a special STD clinic for drug-using prostitutes was selected from an ongoing cohort study of drug users in Amsterdam. Methods : Using Poisson regression, the relative risk (RR) for each outcome was calculated for HIV-positive women compared with HIV-negative women. To determine potential causal relations with immune suppression, associations between disease incidence and immunologic markers (CD4 cell count and anti-CD3 response) were assessed in HIV-positive women. Results : Adjusted for number of clients and frequency of condom use, HIV-positive women were at strong and significantly increased risk for primary genital herpes (RR, 7.64), recurrent herpes (RR, 8.33) and recurrent genital warts (RR, 15.93) ; moderately (significantly) increased risks were found for gonorrhoea (RR, 1.43), trichomoniasis (RR, 1.39), vaginal candidiasis (RR, 2.11) and genital ulcers of unknown aetiology (RR, 2.60). Of these HIV-related outcomes, the risk for recurrent genital herpes and genital warts were strongly associated with decreased CD4 cell counts. Conclusions : HIV-infected women experience an excess morbidity of STD and gynaecologic disorders. The strongly increased risk for genital herpes and warts in HIV-seropositive women indicates a causal relation with HIV. This study emphasizes the need for accessible medical care for drug-using prostitutes.
- Published
- 1995
36. Autogenous vaccine
- Author
-
O. Wiltz, O. H. Wiltz, and M. Torregrosa
- Subjects
Adult ,Male ,medicine.medical_specialty ,HIV Infections ,Podophyllin ,Recurrence ,Surgical oncology ,medicine ,Humans ,Combined Modality Therapy ,Syphilis ,skin and connective tissue diseases ,Papillomaviridae ,Retrospective Studies ,Anus Diseases ,Dichloroacetic Acid ,business.industry ,Gastroenterology ,Interferon-alpha ,virus diseases ,Viral Vaccines ,Retrospective cohort study ,General Medicine ,Middle Aged ,Condyloma Acuminatum ,medicine.disease ,Colorectal surgery ,Surgery ,Vaccination ,Condylomata Acuminata ,Female ,business ,Follow-Up Studies - Abstract
PURPOSE: Treatment of perianal condyloma acuminata is frustrating because most treatment options are fraught with high recurrence rates and patient discomfort. We propose that surgical excision followed by vaccination with an autogenous condyloma acuminata vaccine is the most effective therapy available in primary and recurrent perianal condyloma acuminata. METHODS: Eighty-three patients with perianal condyloma acuminata were treated from 1985 to 1992. Treatment was divided for patients as follows: surgical excision, 20; bichloroacetic acid, 10; podophyllin and interferon A, 5; excision followed by autogenous condyloma acuminata vaccination twice weekly using 0.1 ml subcutaneously for three weeks increasing to 1.0 ml subcutaneously for seven weeks, 43. Syphilis was diagnosed in seven patients; two were human immunovirus-positive. All but three patients were male. Of those patients treated with the vaccination protocol, 25 had primary and 18 had recurrent disease. RESULTS: Recurrence rates were: excision alone and bichloroacetic acid, 50 percent; podophyllin and interferon A, 85 percent; whereas only 4.6 percent recurred when treated with excision and vaccination. Mean follow-up was 13 (range, 6–23) months. All patients treated with the vaccination protocol tolerated the full course of therapy. CONCLUSION: We believe that excision of perianal condyloma acuminata followed by autogenous condyloma acuminata vaccination for approximately ten weeks is the most effective and definitive treatment option and, moreover, should be considered in all patients with perianal condyloma acuminata.
- Published
- 1995
37. Surgical Treatment of Verrucous Carcinoma of the Bladder Unassociated With Bilharzial Cystitis: Case Report and Literature Review
- Author
-
John A. Heaney, Alan R. Schned, Paul M. Snyder, and Pamela I. Ellsworth
- Subjects
medicine.medical_specialty ,Urinary bladder ,Verrucous carcinoma ,business.industry ,Urology ,medicine.medical_treatment ,Middle Aged ,Condyloma Acuminatum ,medicine.disease ,Dermatology ,Surgery ,Perineum ,Cystectomy ,medicine.anatomical_structure ,Urinary Bladder Neoplasms ,Carcinoma ,medicine ,Vagina ,Humans ,Female ,Carcinoma, Verrucous ,business ,Cervix - Abstract
Verrucous carcinoma of the bladder unassociated with bilharzial cystitis is rare with only 6 cases reported to date. Verrucous carcinoma of the bladder, like that involving the cervix, vagina, oral cavity, perineum and lower extremities, may invade surrounding structures but remain surgically curable. Although it is similar to condyloma acuminatum, verrucous carcinoma is considered malignant because of its invasive growth pattern and it should be treated accordingly. However, no evidence of metastases has been noted to date. To our knowledge we report the first case of extravesical extension of verrucous carcinoma of the bladder that was treated successfully by surgical removal.
- Published
- 1995
38. Anal Human Papillomavirus Infection Among Homosexual and Bisexual Men
- Author
-
Paula Breese, John M. Douglas, Kent A. Penley, and Franklyn N. Judson
- Subjects
Adult ,Male ,Microbiology (medical) ,Sexually transmitted disease ,medicine.medical_specialty ,Comorbidity ,Dermatology ,Acquired immunodeficiency syndrome (AIDS) ,Risk Factors ,HIV Seronegativity ,Internal medicine ,HIV Seropositivity ,Prevalence ,medicine ,Humans ,Homosexuality, Male ,Papillomaviridae ,Sida ,Aged ,Subclinical infection ,Anus Diseases ,biology ,business.industry ,Papillomavirus Infections ,Public Health, Environmental and Occupational Health ,HPV infection ,virus diseases ,Middle Aged ,Condyloma Acuminatum ,medicine.disease ,biology.organism_classification ,Tumor Virus Infections ,Cross-Sectional Studies ,Infectious Diseases ,Immunology ,Bisexuality ,business ,Follow-Up Studies - Abstract
BACKGROUND AND OBJECTIVE "High-risk" types of genital human papillomavirus (HPV) infections are associated with anogenital cancer. As these cancers occur more frequently in immunosuppressed individuals, we sought to better characterize type-specific prevalence, clinical spectrum, and risk factors for anal HPV infection among homosexual men. STUDY DESIGN Cross-sectional and follow-up study of 93 HIV-seropositive (HIV+) and 116 HIV-seronegative (HIV-) homo-sexual/bisexual men, with testing of anal swabs for HPV DNA by Virapap/Viratype assay. RESULTS Overall, 57 (61%) HIV+ and 20 (17%) HIV- men had anal HPV detected (P < .0001). HPV types 16/18 were most common, accounting for more than 50% of infections. Among HIV+ men, HPV prevalence increased with declining CD4 cell count: 33% with counts of more than 750, 56% with counts of 200 to 750, and 86% with counts less than 200 (P = .01). HPV infection was also associated with younger age and increasing numbers of lifetime sexual partners for all men. Most infections were subclinical, with clinically apparent infection (anal warts) accounting for 35% of infections in HIV- men, 33% in asymptomatic HIV+ men, and 52% in men with AIDS/ARC. For both HIV- and HIV+ men, rates of anal HPV detection (23% and 60%) were greater than those for the perianal area (5% and 37%) or penile shaft (2% and 7%) (P < .001). Persistence of anal HPV for 6 months was more common among men with AIDS/ARC (95%) than among asymptomatic HIV+ men (62%) or HIV- men (61%) (P < .05). CONCLUSIONS Anal HPV infections are common in homosexual/bisexual men and have a strong relationship to HIV-associated immunosuppression. Because most infections involve "high-risk" types of HPV, studies of their natural history are needed to clarify the risk of anal neoplasia in men with HIV infection.
- Published
- 1995
39. Carbon Dioxide (CO2)-Laser Therapy Cures Macroscopic Lesions, but Viral Genome Is Not Eradicated in Men With Therapy-Resistant HPV Infection
- Author
-
Jan Lassus, Annamari Ranki, Kirsti-Maria Niemi, and Hannu-Pekka Happonen
- Subjects
Male ,Microbiology (medical) ,Sexually transmitted disease ,medicine.medical_specialty ,Pathology ,Penile Diseases ,Biopsy ,medicine.medical_treatment ,Cryotherapy ,Genome, Viral ,Dermatology ,Polymerase Chain Reaction ,Gastroenterology ,Genital warts ,Podophyllin ,Recurrence ,Internal medicine ,medicine ,Humans ,Papillomaviridae ,In Situ Hybridization ,Anus Diseases ,business.industry ,Papillomavirus Infections ,Public Health, Environmental and Occupational Health ,HPV infection ,virus diseases ,Condyloma Acuminatum ,medicine.disease ,Bowenoid papulosis ,Blotting, Southern ,Tumor Virus Infections ,Treatment Outcome ,Infectious Diseases ,Condylomata Acuminata ,Laser Therapy ,Viral disease ,business ,Follow-Up Studies - Abstract
BACKGROUND AND OBJECTIVES We have evaluated the efficacy of CO2-laser in eradicating human papillomavirus (HPV) DNA from genitoanal skin lesions. STUDY DESIGN Biopsies of 38 male patients with histologically confirmed HPV-infection after an average of 2 years of follow-up were analyzed. Post-treatment biopsies were obtained from all residual or recurrent HPV-suspect (acetowhite) lesions in 23 patients. RESULTS After an average of three separate CO2-laser treatments, 15 of 38 patients were devoid of any clinical or acetowhite lesions. By in situ hybridization (ISH), the frequency of HPV-types 6/11 decreased from 52% to 26%, and HPV-types 16/18 decreased from 48% to 17%, respectively, in 23 patients biopsied twice. When ISH-negative biopsies were further analyzed with polymerase chain reaction (PCR) and southern blotting (SB) for HPV-16, HPV-types 16/18 were detected in a total of 65% of biopsies before CO2-laser therapy, and in 61% after the therapy. The cure rate achieved with CO2-laser was 39% (15/38) according to clinical, 61% (14/23) according to histopathological, and 26% (6/23) according to molecular biological criteria. The frequency of Bowenoid papulosis was reduced from 57% (13/23) to 17% (4/23). CONCLUSIONS Although CO2-laser is ineffective in eradicating HPV genome from therapy-resistant penile warts, the treatment reduces the recurrence of atypical changes and visible warts.
- Published
- 1994
40. Histologic Correlates of Vulvar Human Papillomavirus Infection in Children and Young Adults
- Author
-
Craighill M, Christopher P. Crum, Harry P.W. Kozakewich, O'Connell B, and Catherine M. McLachlin
- Subjects
Adult ,Sexually transmitted disease ,medicine.medical_specialty ,Pathology ,Biology ,Pathology and Forensic Medicine ,Vulva ,Koilocytotic Atypia ,medicine ,Humans ,Sex organ ,Child ,Papillomaviridae ,Observer Variation ,Papillomavirus Infections ,virus diseases ,Condyloma Acuminatum ,female genital diseases and pregnancy complications ,Tumor Virus Infections ,medicine.anatomical_structure ,Sexual abuse ,DNA, Viral ,Vagina ,Female ,Surgery ,Histopathology ,Vulvar Diseases ,Anatomy ,Polymorphism, Restriction Fragment Length - Abstract
Two clinically important issues in the treatment of vulvar wartlike lesions are the histologic criteria for the recognition of human papilloma virus (HPV)-related lesions and the exclusion of lesions derived from cutaneous rather than genital HPV types. We analyzed a series of 70 biopsies from the vulva or distal vagina of 57 children and 13 young adults for HPV nucleic acids by polymerase chain reaction (PCR) amplification and typed the isolates following isotope labeling and restriction digestion (restriction fragment length polymorphism [RFLP] analysis). Lesions were classified as condyloma, suggestive of condyloma (papillary/verrucous architecture without koilocytotic atypia), or nonspecific epithelial alterations. Three observers independently agreed on the presence of papillary/verrucous architecture and koilocytotic atypia with a high degree of concordance (kappa = 0.74 and 0.71, respectively). By RFLP analysis, 77% of the lesions diagnosed as condyloma and 68% of those diagnosed as suggestive of condyloma contained HPV nucleic acids versus 9% of the nonspecific group. The HPV types identified were HPV 6 (67%), HPV 11 (17%), HPV 16 (3%), and unknown types (14%). No cutaneous HPV types were identified. Three patients with unknown HPV types had a history of sexual abuse, implying a genital source. These findings indicate that verrucopapillary external genital lesions, as defined in this report, are likely to be associated with HPV and that the vast majority contain genital HPV types irrespective of histologic presentation.
- Published
- 1994
41. Detection of Human Papillomavirus by the Polymerase Chain Reaction in Histologically Normal Penile Skin Adjacent to Penile Warts
- Author
-
P C Winter, R D Maw, M Walsh, Kathleen A. Ward, and W W Dinsmore
- Subjects
Adult ,Male ,Microbiology (medical) ,Sexually transmitted disease ,Pathology ,medicine.medical_specialty ,Penile Diseases ,Adolescent ,Dermatology ,Polymerase Chain Reaction ,law.invention ,Recurrence ,law ,medicine ,Humans ,Prospective Studies ,Prospective cohort study ,Papillomaviridae ,Polymerase chain reaction ,Skin ,business.industry ,Public Health, Environmental and Occupational Health ,HPV infection ,virus diseases ,Histology ,Sequence Analysis, DNA ,Condyloma Acuminatum ,medicine.disease ,Exact test ,Infectious Diseases ,medicine.anatomical_structure ,Condylomata Acuminata ,DNA, Viral ,Female ,business ,Penis - Abstract
Background and objectives Anogenital warts frequently recur following ablative treatment, and in the female, has been attributed to the presence of latent HPV infection outside the treatment margins. Goal of this study To determine whether HPV DNA sequences were detected by PCR in histologically normal penile skin adjacent to penile warts and to correlate recurrence of warts following surgical ablation to the presence of HPV DNA in histologically normal penile skin. Study design Prospective cohort study of 25 heterosexual men with penile warts. Biopsies of clinically healthy penile skin 1 cm from the nearest penile lesion (wart with/without surrounding acetowhite changes) were processed for histology and HPV DNA analysis. The penile wart was processed for HPV DNA analysis only. Recurrence of penile warts was correlated to HPV status of adjacent histologically normal penile skin using Fisher's exact test (FET). Results Sequences homologous to HPV DNA were detected in 77% of biopsies of histologically normal penile skin. Agreement in HPV DNA type between penile wart and the adjacent histologically normal penile skin was only 30%. Recurrence of warts was noted in 46% of men by 16 weeks, and was not predicted by the detection of HPV DNA in the adjacent histologically normal penile skin (P = 0.16, FET). Conclusions These findings suggest that extending the treatment margins 1 cm beyond the visible lesion is ineffective in eradicating the virus and preventing recurrence of warts.
- Published
- 1994
42. Efficacy of imiquimod on external anogenital warts in HIV-infected patients previously treated by highly active antiretroviral therapy
- Author
-
Isabelle Bourgault-Villada, Caroline Roudier-Pujol, Philippe Saiag, and Mira Pavlovic
- Subjects
Sexually transmitted disease ,Chemotherapy ,biology ,business.industry ,medicine.medical_treatment ,Immunology ,Imiquimod ,Condyloma Acuminatum ,biology.organism_classification ,medicine.disease ,Infectious Diseases ,Acquired immunodeficiency syndrome (AIDS) ,Immunopathology ,medicine ,Immunology and Allergy ,Viral disease ,Sida ,business ,medicine.drug - Published
- 2002
43. PRIMARY TREATMENT OF CONDYLOMATA ACUMINATA WITH VIABLE BACILLUS CALMETTE-GUERIN
- Author
-
Hartwig Büttner, Andreas Böhle, and Dieter Jocham
- Subjects
Male ,Sexually transmitted disease ,medicine.medical_specialty ,Penile Diseases ,Urology ,medicine.medical_treatment ,Genital warts ,Adjuvants, Immunologic ,Humans ,Medicine ,skin and connective tissue diseases ,business.industry ,virus diseases ,Immunotherapy ,Condyloma Acuminatum ,medicine.disease ,Dermatology ,Surgery ,medicine.anatomical_structure ,Condylomata Acuminata ,BCG Vaccine ,Primary treatment ,Viral disease ,business ,Adjuvant ,Penis ,Follow-Up Studies - Abstract
Condylomata acuminata or genital warts are caused by human papillomavirus. Prevalence data show that infection rates are increasing. To our knowledge we report the first successful primary treatment of genital warts with topical bacillus Calmette-Guerin (BCG) and provide long-term followup in a group of adjuvant treated patients with recurrent condylomata acuminata.In 10 consecutive men viable BCG was directly applied to the condylomata acuminata lesions once weekly for 6 weeks. In nonresponding patients another course of 9 applications was administered for 3 weeks.A complete response was achieved in 6 of the 10 men after 1 or 2 treatment cycles. All responding patients are disease-free at a median followup of 9.2 months (range 4 to 12). One patient achieved partial regression of the lesions and in 3 the condylomata did not disappear. Side effects were rare and mild. Long-term followup in 6 adjuvant treated patients with rapidly recurrent condylomata acuminata showed no further recurrence after topical BCG in 5 at a median of 30.8 months (range 29 to 50).Topical application of viable BCG has therapeutic activity as adjuvant and primary treatment for penile condylomata acuminata with negligible side effects. Long-term followup implies the prevention of recurrent disease.
- Published
- 2001
44. Epidemiology of adult sexually transmitted disease agents in children being evaluated for sexual abuse
- Author
-
L A Rockwell, D L Ingram, V D Everett, Pauline R. Lyna, and S T White
- Subjects
Microbiology (medical) ,Child abuse ,Sexually transmitted disease ,medicine.medical_specialty ,Pathology ,Sexually Transmitted Diseases ,urologic and male genital diseases ,medicine.disease_cause ,Prevalence ,Humans ,Medicine ,Prospective Studies ,Child ,business.industry ,Obstetrics ,Infant ,Child Abuse, Sexual ,Condyloma Acuminatum ,medicine.disease ,female genital diseases and pregnancy complications ,Infectious Diseases ,Sexual abuse ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Neisseria gonorrhoeae ,Syphilis ,Bacterial vaginosis ,business ,Chlamydia trachomatis - Abstract
This prospective study describes the epidemiology of adult sexually transmitted disease agents in 1538 children ages 1 to 12 years being evaluated for possible sexual abuse. Infections with these agents were related to the presence or absence of a history of sexual contact. Neisseria gonorrhoeae (GC) was found in 2.8% (41 of 1469); human papillomavirus presenting as condyloma acuminata, 1.8%; Chlamydia trachomatis, 1.2% (17 of 1473); Treponema pallidum (syphilis), 0.1% (1 of 1263); and herpes simplex virus, 0.1%. Overall a history of sexual contact was present in 83% of children with N. gonorrhoeae; condyloma acuminata, 43%; Chlamydia trachomatis, 94%; syphilis, 0%; and herpes simplex virus, 50%. Selected vaginal discharges were examined for Trichomonas vaginalis and bacterial vaginosis. In children comprehending questions regarding sexual contact (i.e. were "verbal"), 89% with N. gonorrhoeae, 100% with Chlamydia trachomatis and 63% with condyloma acuminata had a history of sexual contact, indicating that in "verbal" children any infection with N. gonorrhoeae or C. trachomatis was highly associated with sexual contact.
- Published
- 1992
45. Self-treatment Using a 0.5% Podophyllotoxin Cream of External Genital Condylomata Acuminata in Women
- Author
-
D Hellberg and G. Von Krogh
- Subjects
Adult ,Microbiology (medical) ,medicine.medical_specialty ,Self-treatment ,Administration, Topical ,Self Administration ,Dermatology ,Placebo ,Ointments ,Double blind study ,Double-Blind Method ,Humans ,Medicine ,Sex organ ,Podophyllotoxin ,Vulvar Neoplasms ,business.industry ,Public Health, Environmental and Occupational Health ,Condyloma Acuminatum ,Anus Neoplasms ,Surgery ,Clinical trial ,Infectious Diseases ,Condylomata Acuminata ,Female ,business ,Self-administration ,Follow-Up Studies ,medicine.drug - Abstract
In a double-blind, placebo-controlled study, self-treatment with a 0.5% podophyllotoxin cream was evaluated among 60 women afflicted solely with outer vulvoanal warts; 12 women received treatment with placebo cream and 48 women with active substance, administered twice daily in 3-day cycles once weekly for up to 3 weeks. Patients who were not completely cured after three cycles were classified as treatment failures. Four patients treated with podophyllotoxin cream were excluded: two were considered drop-outs, another patient was concurrently afflicted with intraanal warts, and a fourth patient refused further therapy with the cream due to the severity of local side effects occurring from the first course of therapy. Of the remaining 44 patients treated with active substance, the primary cure rates were 43%, 66%, and 91% after 1, 2, and 3 treatment cycles, respectively. Within a 3-month follow-up period, 6 (14%) patients who were originally considered cured exhibited some degree of either "recurrence" or "reoccurrence". Thus, a complete and permanent cure from podophyllotoxin cream occurred in 38 out of 44 patients (77%). Placebo lacked therapeutic influence. A slight-to-moderate tenderness, pain, burning, or all of the above in the treated areas was noted by more than 60% of the women who were treated with the podophyllotoxin cream.
- Published
- 1992
46. Colpectomy after vaginoplasty in transsexuals
- Author
-
Refaat B. Karim, A.Anneke van Engeland, J. Joris Hage, and Paul J. van Diest
- Subjects
Sexually transmitted disease ,medicine.medical_specialty ,business.industry ,virus diseases ,Obstetrics and Gynecology ,Condyloma Acuminatum ,Surgery ,Transplantation ,Plastic surgery ,medicine.anatomical_structure ,Clitoroplasty ,Vagina ,medicine ,Vaginoplasty ,Sex organ ,skin and connective tissue diseases ,business - Abstract
Background: Penile amputation, vaginoplasty, and clitoroplasty help male-to-female transsexuals accept their bodies and increase psychosocial function. Subsequent colpectomy is unusual. Cases: We report three patients in whom complicated, long-term problems subsequent to vaginoplasty led to total colpectomy in one case of neovaginal overgrowth of condylomata acuminata, and in two cases of colitis in rectosigmoid transplants used for neovaginoplasties. Conclusion: Before inversion of penile skin, in cases in which the genital skin has condylomata, the risk of condylomata overgrowth might be anticipated. Rectosigmoid vaginoplasty might result in therapy-resistent colitis, which also could lead to colpectomy.
- Published
- 2000
47. Human Papillomavirus Infection of the Oral Mucosa
- Author
-
Brad Neville, Jens Pindborg, Jonathan A. Garlick, and Lome B. Taichman
- Subjects
Pathology ,medicine.medical_specialty ,Focal Epithelial Hyperplasia ,Dermatology ,Pathology and Forensic Medicine ,Lesion ,medicine ,Humans ,Oral mucosa ,Papillomaviridae ,Leukoplakia ,biology ,business.industry ,Mouth Mucosa ,virus diseases ,General Medicine ,Condyloma Acuminatum ,medicine.disease ,biology.organism_classification ,Koilocyte ,Tumor Virus Infections ,medicine.anatomical_structure ,Squamous cell papilloma ,Mouth Neoplasms ,medicine.symptom ,Mouth Diseases ,business ,Precancerous Conditions - Abstract
This article reviews the lesions of oral mucosa that contain human papillomavirus (HPV). These HPV-associated lesions can be classified into two broad types on the basis of their biologic behavior, benign lesions and premalignant malignant or malignant lesions. Benign oral lesions include squamous cell papilloma (SCP), verruca vulgaris (VV), condyloma acuminatum (CA), and focal epithelial hyperplasia (FEH). Of these entities, VV, CA, and FEH demonstrate characteristic HPV-induced cytopathic effects, whereas SCP infrequently shows such changes. All of these lesions show a clear association with HPV. Premalignant and malignant oral lesions include leukoplakia and squamous cell carcinoma. The etiologic role of HPV in these lesions is still unclear. Koilocytosis is the most common cytopathic effect seen in both groups of lesions. Even though it is sometimes difficult to distinguish between hyperplastic lesions such as SCP, VV, and CA, clinical and certain histologic features can facilitate the diagnosis. Although exceptions do exist, each of the two classes of lesions is most commonly associated with particular HPV types. The benign oral lesions are associated with HPV 2, 4, 6, 11, 13, and 32; the malignant oral lesions are associated with HPV 16 and 18. No preferential association has been demonstrated between specific HPV types and a particular oral lesion.
- Published
- 1991
48. Genital Human Papillomavirus Infections in Patients Attending an Inner-City STD Clinic
- Author
-
Phyllis Ray, Geraldine M. McQuillan, J E Horn, Keerti V. Shah, E W Hook rd, Thomas C. Quinn, Richard W. Daniel, and Prabodh K. Gupta
- Subjects
Adult ,Microbiology (medical) ,Sexually transmitted disease ,medicine.medical_specialty ,Adolescent ,Urban Population ,Genital Neoplasms, Female ,Population ,Sexually Transmitted Diseases ,Papanicolaou stain ,Cervix Uteri ,Dermatology ,Genital warts ,Prevalence ,medicine ,Humans ,Papillomaviridae ,education ,Vaginal Smears ,education.field_of_study ,biology ,business.industry ,Public Health, Environmental and Occupational Health ,HPV infection ,Nucleic Acid Hybridization ,virus diseases ,Condyloma Acuminatum ,biology.organism_classification ,medicine.disease ,female genital diseases and pregnancy complications ,Blotting, Southern ,Tumor Virus Infections ,Infectious Diseases ,Condylomata Acuminata ,Baltimore ,DNA, Viral ,Immunology ,Genital neoplasm ,Female ,business ,Genital Diseases, Female ,Papanicolaou Test - Abstract
One hundred and sixteen consecutive women attending a Baltimore City STD clinic were studied for the prevalence of human papillomavirus (HPV) infection of the genital tract using three criteria: presence of clinically recognized (visible) genital warts, cytopathologic evidence suggestive of HPV infection in a Papanicolaou smear, and analysis of cervical scrapes for genital tract HPV genomic sequences by Southern hybridization. The women were young (median age: 22 years) and more than 80% had a history of one or more STDs. The prevalences were 17% for visible warts, 41% for cytologic findings suggestive of HPV infection, and 12% for HPV DNA in cervical scrapes. Comparing the results of the three techniques, HPV DNA was found significantly more often in cytopathology-positive women than in cytopathology-negative women (18% vs. 5%, P = 0.05) and in women with visible warts than in women without visible warts (29% vs. 6%, P = 0.01). Visible warts were more common in women with HPV-DNA-positive cervical scrapes than in HPV-negative women (50% vs. 14%, P = .01). Although 52% of women were judged as infected by at least one of the three criteria, only 4% were infected by using all three criteria. The prevalence of infection was 23% if cytopathology alone was excluded as evidence of HPV infection. These results indicate the difficulty in an accurate estimation of the prevalence of HPV infections, even in a high-risk population.
- Published
- 1991
49. TREATMENT OF RECURRENT PENILE CONDYLOMATA ACUMINATA WITH EXTERNAL APPLICATION AND INTRAURETHRAL INSTILLATION OF BACILLUS CALMETTE-GUERIN
- Author
-
A. Böhle, Christian Doehn, Dieter Jocham, and Ingo Kausch
- Subjects
Sexually transmitted disease ,Adult ,Male ,medicine.medical_specialty ,Penile Diseases ,medicine.medical_treatment ,Administration, Topical ,Urology ,Urinary Bladder ,Administration, Cutaneous ,Adjuvants, Immunologic ,Urethra ,Recurrence ,medicine ,Combined Modality Therapy ,Humans ,Papillomaviridae ,skin and connective tissue diseases ,biology ,medicine.diagnostic_test ,business.industry ,Papillomavirus Infections ,virus diseases ,Immunotherapy ,Cystoscopy ,Condyloma Acuminatum ,biology.organism_classification ,Surgery ,Tumor Virus Infections ,medicine.anatomical_structure ,Condylomata Acuminata ,BCG Vaccine ,Laser Therapy ,business ,Penis ,Follow-Up Studies - Abstract
Condylomata acuminata are caused by human papillomavirus infection. Despite numerous treatment modalities these patients often demonstrate recurrent disease. We report initial experience with bacillus Calmette-Guerin (BCG) therapy in patients not responding to standard treatment.Between October 1994 and March 1997, 6 men with rapidly recurrent external and intraurethral condylomata acuminata underwent BCG therapy after initial laser treatment. External application and intraurethral instillation of BCG were performed 6 times in weekly intervals. Followup studies included examination and endoscopic inspection of the urethra and bladder.Of the patients 3 completed 1 course of BCG and had no relapse of condylomata acuminata, 2 underwent a second course of BCG and 1 had relapse, and 1 had relapse after discontinuing therapy due to penile edema. The annual recurrence rate decreased from 3.2 before to 0.75 after BCG therapy (p0.05, test of equality of 2 percentages).Immunotherapy with BCG is accepted treatment for superficial transitional cell carcinoma. The BCG induced immune response appears to reduce the recurrence rate in patients with condylomata acuminata.
- Published
- 1998
50. Anogenital Warts
- Author
-
Anneke M. Lammers, Sharon M. Couwenberg, Eric M van der Snoek, and Anton M. van Loon
- Subjects
Adult ,Male ,Microbiology (medical) ,Health Knowledge, Attitudes, Practice ,Adolescent ,Sexual Behavior ,media_common.quotation_subject ,Information Seeking Behavior ,Self-concept ,Shame ,Dermatology ,Genital warts ,Risk-Taking ,Quality of life ,Surveys and Questionnaires ,medicine ,Humans ,Depression (differential diagnoses) ,Netherlands ,media_common ,First episode ,Anus Diseases ,business.industry ,Papillomavirus Infections ,Public Health, Environmental and Occupational Health ,virus diseases ,Patient Acceptance of Health Care ,Condyloma Acuminatum ,Anus ,medicine.disease ,Self Concept ,Military Personnel ,Infectious Diseases ,medicine.anatomical_structure ,Condylomata Acuminata ,Quality of Life ,Female ,business ,Clinical psychology - Abstract
Background Anogenital warts are one of the most prevalent sexually transmitted virus infections in the Netherlands and cause frustration, shame, and even depression. This study was performed to determine the effect of having anogenital warts on the quality of life in Dutch soldiers with the use of a dermatology-specific quality of life (QoL) questionnaire. Methods We used the Skindex-29 QoL questionnaire in 100 predominantly heterosexual soldiers with clinically confirmed first episode of condylomata acuminate in this study. Results Results confirmed that first episodes of anogenital warts cause high mean scores on subscale Emotions with lower scores on the subscales Symptoms and Functioning. Sex, age, educational level, anatomical site, or number of anatomical sites did not influence the outcome in this study. Conclusions Having anogenital warts influences QoL, especially with regard to intimacy, shame, and concern. Our data show that the Skindex-29 QoL questionnaire can be easily used in these patients with good internal consistency. Clinicians should be aware of the great emotional impact of anogenital warts on their patients.
- Published
- 2013
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.